Co-segregation of DM2 with a recessive CLCN1 mutation in juvenile onset of myotonic dystrophy type 2

被引:0
|
作者
Rosanna Cardani
Marzia Giagnacovo
Annalisa Botta
Fabrizio Rinaldi
Alessandra Morgante
Bjarne Udd
Olayinka Raheem
Sini Penttilä
Tiina Suominen
Laura V. Renna
Valeria Sansone
Enrico Bugiardini
Giuseppe Novelli
Giovanni Meola
机构
[1] IRCCS Policlinico San Donato,Lab of Muscle Histopathology and Molecular Biology
[2] University of Milan,CMN
[3] University of Pavia,Neuromuscular Disease Center, IRCCS Policlinico San Donato
[4] Tor Vergata University of Rome,Department of Animal Biology
[5] University of Tampere,Department of Biopathology and Diagnosing Imaging
[6] University of Helsinki,Neuromuscular Research Unit
[7] University of Helsinki,Department of Medical Genetics, Haartman Institute
[8] Tampere University Hospital,Department of Medical Genetics, Folkhälsan Institute of Genetics
[9] Vaasa Central Hospital,Department of Neurology
[10] University of Milan,Department of Neurology
[11] San Peter Hospital,Department of Neurology, IRCCS Policlinico San Donato
[12] National Agency for the Evaluation of Universities and Research,undefined
[13] ANVUR,undefined
来源
Journal of Neurology | 2012年 / 259卷
关键词
Myotonic dystrophy type 2; Juvenile case; Muscle pathology; Myotonia congenita;
D O I
暂无
中图分类号
学科分类号
摘要
Myotonic dystrophy type 2 (DM2) is a common adult onset muscular dystrophy caused by a dominantly transmitted (CCTG)n expansion in intron 1 of the CNBP gene. In DM2 there is no obvious evidence for an intergenerational increase of expansion size, and no congenital cases have been confirmed. We describe the clinical and histopathological features, and provide the genetic and molecular explanation for juvenile onset of myotonia in a 14-year-old female with DM2 and her affected mother presenting with a more severe phenotype despite a later onset of symptoms. Histological and immunohistochemical findings correlated with disease severity or age at onset in both patients. Southern blot on both muscle and blood samples revealed only a small increase in the CCTG repeat number through maternal transmission. Fluorescence in situ hybridization, in combination with MBNL1 immunofluorescence on muscle sections, showed the presence of mutant mRNA and MBNL1 in nuclear foci; the fluorescence intensity and its area appeared to be similar in the two patients. Splicing analysis of the INSR, CLCN1 and MBNL1 genes in muscle tissue demonstrates that the level of aberrant splicing isoforms was lower in the daughter than in the mother. However, in the CLCN1 gene, a heterozygous mutation c.501C>G p.F167L was present in the daughter’s DNA and found to be maternally inherited. Biomolecular findings did not explain the unusual young onset in the daughter. The co-segregation of DM2 with a recessive CLCN1 mutation provided the explanation for the unusual clinical findings.
引用
收藏
页码:2090 / 2099
页数:9
相关论文
共 50 条
  • [31] Severe myotonia in myotonic dystrophy type 2 caused by CLCN1 or SCN4A mutations acting as modifying factors
    Meola, G.
    Bugiardini, E.
    Cardani, R.
    Botta, A.
    Rossi, G.
    Merli, I.
    Fossati, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 112 - 112
  • [32] Proof of genetic heterogeneity in the proximal myotonic myopathy syndrome (PROMM) and its relationship to myotonic dystrophy type 2 (DM2)
    Kress, W
    Mueller-Myhsok, B
    Ricker, K
    Schneider, C
    Koch, MC
    Toyka, KV
    Mueller, CR
    Grimm, T
    NEUROMUSCULAR DISORDERS, 2000, 10 (07) : 478 - 480
  • [33] Differences in aberrant expression and splicing of genes involved in Ca2+ metabolism between myotonic dystrophy type 2 (DM2) and type 1 (DM1)
    Vihola, A.
    Sirito, M.
    Bachinski, L.
    Olufemi, S.
    Raheem, O.
    Suominen, T.
    Udd, B.
    Krahe, R.
    NEUROMUSCULAR DISORDERS, 2007, 17 (9-10) : 858 - 858
  • [34] Health-related quality of life in myotonic dystrophy type 1 (DM1) and type 2 (DM2): Correlations with indexes of cognitive and behavioral abnormalities
    Sansone, V
    Gandossini, S
    Cotelli, M
    Calabria, M
    Zanetti, O
    Apolone, G
    Meola, G
    NEUROLOGY, 2006, 66 (05) : A151 - A152
  • [35] Correction of Clcn1 alternative splicing reverses muscle fiber type transition in mice with myotonic dystrophy
    Ningyan Hu
    Eunjoo Kim
    Layal Antoury
    Thurman M. Wheeler
    Nature Communications, 14
  • [36] Correction of Clcn1 alternative splicing reverses muscle fiber type transition in mice with myotonic dystrophy
    Hu, Ningyan
    Kim, Eunjoo
    Antoury, Layal
    Wheeler, Thurman M.
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [37] The frequency and severity of cardiac involvement in myotonic dystrophy type 2 (DM2): Long-term outcomes
    Sansone, V. A.
    Brigonzi, E.
    Schoser, B.
    Villani, S.
    Gaeta, M.
    De Ambroggi, G.
    Bandera, F.
    De Ambroggi, L.
    Meola, G.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (02) : 1147 - 1153
  • [38] (CCUG)n RNA toxicity in a Drosophila model of myotonic dystrophy type 2 (DM2) activates apoptosis
    Yenigun, Vildan Betul
    Sirito, Mario
    Amcheslavky, Alla
    Czernuszewicz, Tomek
    Colonques-Bellmunt, Jordi
    Garcia-Alcover, Irma
    Wojciechowska, Marzena
    Bolduc, Clare
    Chen, Zhihong
    Lopez Castel, Arturo
    Krahe, Ralf
    Bergmann, Andreas
    DISEASE MODELS & MECHANISMS, 2017, 10 (08) : 993 - 1003
  • [39] Type 2 nuclear clump fiber atrophy is an early finding in muscles of asymptomatic patients with myotonic dystrophy type 2 (DM2)
    Meola, G
    Sansone, V
    Vihola, A
    Rotondo, G
    Mancinelli, E
    Pazzi, A
    Krahe, R
    Udd, B
    NEUROMUSCULAR DISORDERS, 2003, 13 (7-8) : 664 - 664
  • [40] Molecular diagnosis by FISH (fluorescent in situ hybridization) on muscle biopsy from myotonic dystrophy type 2 (DM2)
    Cardani, R
    Mancinelli, E
    Rotondo, G
    Krahe, R
    Meola, G
    NEUROMUSCULAR DISORDERS, 2004, 14 (8-9) : 587 - 587